San Diego, CA -- (SBWIRE) -- 11/17/2014 -- An investigation on behalf of investors of Solazyme Inc (NASDAQ:SZYM) shares over potential securities laws violations by Solazyme and certain of its directors and officers in connection certain financial statements was announced.

Investors who purchased shares of Solazyme Inc (NASDAQ:SZYM) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Solazyme Inc (NASDAQ:SZYM) concerning whether a series of statements by Solazyme regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

In February 2014 Solazyme Inc reported its fourth quarter and full year 2013 results. Solazyme Inc reported that annual Total Revenue declined from $44.11 million in 2012 to $39.75 million in 2013 and that its Net Loss increased from $83.13 million in 2012 to $116.39 million in 2013. Shares of Solazyme Inc (NASDAQ:SZYM) grew to as high as $14.00 per share in March 2014.

Since then NASDAQ:SZYM shares have lost significant value.

On May 5, 2014, Solazyme Inc reported its first quarter 2014 results. Solazyme Inc announced that its first quarter Revenue rose from $6.68 million in 2013 to $12.39 million in 2014 and that its first quarter Net Loss increased from $26.52 million in 2013 to $34.68 million in 2014. NASDAQ:SYZM shares declined to as low as $9.00 per share in later May 2014.

On July 30, 2014, Solazyme Inc reported its second quarter 2014 results. Solazyme Inc announced that second quarter Revenue rose from $11.17 million in 2013 to $15.93 million in 2014 and that its second quarter Net Loss increased from $25.82 million in 2013 to $42.91 million in 2014.

On November 5, 2014, Solazyme Inc reported its third quarter 2014 results. Solazyme Inc announced that its third quarter Revenue rose from $10.62 million in 2013 to $17.55 million in 2014 and that its third quarter Net Loss increased from $30.7 million in 2013 to $39.67 million in 2014.

Shares of Solazyme Inc (NASDAQ:SZYM) declined to as low as $2.89 per share on November 6, 2014. In fact, NASDAQ:SZYM shares declined from as high as $14 per share in early 2014 to under $3 per share in early November 2014.

On November 13, 2014, NASDAQ:SZYM shares closed at $3.44 per share.

Those who purchased shares of Solazyme Inc have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com